Precigen, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Precigen, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 0 of 3. Less steady than 86% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-18.4×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 57% of Healthcare companies in United States.
Cash Locked Ratio
$20For every $100 of sales, $20 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $37 tied up three years earlier.
Less money tied up than 57% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 0/3Sales grew in 1 of the last 3 years; profit grew in 0 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 64%
Sales fell 64% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-64% / -28%In 3 years sales changed by -64% while total assets changed by -28%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-77.3×Operating cash was negative last year, while some debt falls due within a year.
Lower than 80% of Healthcare companies in United States.
Cash Cushion Ratio
−0%Debt, after subtracting cash, equals 0% of its market value (net debt).
Lower than 67% of Healthcare companies in United States.
Tangible Assets Ratio
88%Of every $100 the company owns, $88 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 59% of Healthcare companies in United States.
Tangible Net Worth Ratio
12%Of every $100 of net worth, $12 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 68% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Precigen, Inc. made a loss over the last year. Precigen, Inc. owes $0.74 for every $1 it owns. Precigen, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossPrecigen, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
52.50The share price is 52.50 times Precigen, Inc.'s book value per share, higher than 98% of Healthcare companies in United States.
Market cap
$2.3 BThe total market value of all of Precigen, Inc.'s shares at today's price (share price × number of shares), larger than 77% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$44 MWhat Precigen, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.12Net worth divided by the number of shares. The share price of $6.39 is 52.5 times this, which is the P/B above.
Return on equity (ROE)
-837.1%Precigen, Inc. lost 837.1% of its shareholders' money over the last year, lower than 96% of Healthcare companies in United States.
Owes vs Owns
0.74×Precigen, Inc. owes $0.74 for every $1 it owns (moderate), higher than 74% of Healthcare companies in United States.
Dividend yield
NonePrecigen, Inc. does not currently pay a dividend.
Revenue growth
+147%Revenue rose 147% in the year to Dec 2025, and shrank 29% a year on average over 3 years.
Profit growth
LossPrecigen, Inc. made a loss in each of the last two years.
Profit margin
-2588.2%Precigen, Inc. lost $2588 for every $100 of revenue.
Interest cover
Not coveredPrecigen, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtPrecigen, Inc. had $0 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Precigen, Inc.: $2.3 B ÷ $44 M (30 Jun 2026) = 52.5.
What is Precigen, Inc.'s return on equity?
Precigen, Inc. lost 837.1% of its shareholders' money over the last year, lower than 96% of Healthcare companies in United States.
How much does Precigen, Inc. owe compared with what it owns?
Precigen, Inc. owes $0.74 for every $1 it owns (moderate), higher than 74% of Healthcare companies in United States.
Does Precigen, Inc. pay a dividend?
No. Precigen, Inc. does not currently pay a dividend.
Is Precigen, Inc.'s revenue growing?
Revenue rose 147% in the year to Dec 2025, and shrank 29% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.